Creative Financial Designs’s Royalty Pharma RPRX Stock Holding History

Creative Financial Designs’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.34K	Buy	+28	New	+$1.23K	﹤0.01%	1834

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Creative Financial Designs's RPRX Position: Q1 2026 in Review

Creative Financial Designs opened a new position in Royalty Pharma (RPRX) in Q1 2026: 28 shares worth $1.34K. The stake represents ﹤0.01% of the portfolio and ranks #1834 among its holdings.

587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

Creative Financial Designs held 28 shares of Royalty Pharma worth $1.34K as of Q1 2026.
Royalty Pharma was a new Creative Financial Designs position in Q1 2026.
Royalty Pharma made up ﹤0.01% of Creative Financial Designs's portfolio in Q1 2026, its #1834 holding.
587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.